207 related articles for article (PubMed ID: 32157115)
1. Chemokine releasing particle implants for trapping circulating prostate cancer cells.
Huang Y; Hakamivala A; Li S; Nair A; Saxena R; Hsieh JT; Tang L
Sci Rep; 2020 Mar; 10(1):4433. PubMed ID: 32157115
[TBL] [Abstract][Full Text] [Related]
2. CXCR4 pharmacogical inhibition reduces bone and soft tissue metastatic burden by affecting tumor growth and tumorigenic potential in prostate cancer preclinical models.
Gravina GL; Mancini A; Muzi P; Ventura L; Biordi L; Ricevuto E; Pompili S; Mattei C; Di Cesare E; Jannini EA; Festuccia C
Prostate; 2015 Sep; 75(12):1227-46. PubMed ID: 26073897
[TBL] [Abstract][Full Text] [Related]
3. Suppression of prostate cancer cell rolling and adhesion to endothelium by 1α,25-dihydroxyvitamin D3.
Hsu JW; Yasmin-Karim S; King MR; Wojciechowski JC; Mickelsen D; Blair ML; Ting HJ; Ma WL; Lee YF
Am J Pathol; 2011 Feb; 178(2):872-80. PubMed ID: 21281819
[TBL] [Abstract][Full Text] [Related]
4. E-selectin ligand-1 controls circulating prostate cancer cell rolling/adhesion and metastasis.
Yasmin-Karim S; King MR; Messing EM; Lee YF
Oncotarget; 2014 Dec; 5(23):12097-110. PubMed ID: 25301730
[TBL] [Abstract][Full Text] [Related]
5. CXCL12 loaded-dermal filler captures CXCR4 expressing melanoma circulating tumor cells.
Ieranò C; D'Alterio C; Giarra S; Napolitano M; Rea G; Portella L; Santagata A; Trotta AM; Barbieri A; Campani V; Luciano A; Arra C; Anniciello AM; Botti G; Mayol L; De Rosa G; Pacelli R; Scala S
Cell Death Dis; 2019 Jul; 10(8):562. PubMed ID: 31332163
[TBL] [Abstract][Full Text] [Related]
6. CD26/dipeptidyl peptidase IV regulates prostate cancer metastasis by degrading SDF-1/CXCL12.
Sun YX; Pedersen EA; Shiozawa Y; Havens AM; Jung Y; Wang J; Pienta KJ; Taichman RS
Clin Exp Metastasis; 2008; 25(7):765-76. PubMed ID: 18563594
[TBL] [Abstract][Full Text] [Related]
7. Pilot and feasibility study of serum chemokines as markers to distinguish prostatic disease in men with low total serum PSA.
Macoska JA; Begley LA; Dunn RL; Siddiqui J; Wei JT; Sarma AV
Prostate; 2008 Mar; 68(4):442-52. PubMed ID: 18196514
[TBL] [Abstract][Full Text] [Related]
8. Primary prostate cancer educates bone stroma through exosomal pyruvate kinase M2 to promote bone metastasis.
Dai J; Escara-Wilke J; Keller JM; Jung Y; Taichman RS; Pienta KJ; Keller ET
J Exp Med; 2019 Dec; 216(12):2883-2899. PubMed ID: 31548301
[TBL] [Abstract][Full Text] [Related]
9. Tumor cell-specific blockade of CXCR4/SDF-1 interactions in prostate cancer cells by hTERT promoter induced CXCR4 knockdown: A possible metastasis preventing and minimizing approach.
Xing Y; Liu M; Du Y; Qu F; Li Y; Zhang Q; Xiao Y; Zhao J; Zeng F; Xiao C
Cancer Biol Ther; 2008 Nov; 7(11):1839-48. PubMed ID: 18836306
[TBL] [Abstract][Full Text] [Related]
10. Development of 3D Lymph Node Mimetic for Studying Prostate Cancer Metastasis.
Hakamivala A; Huang Y; Chang YF; Pan Z; Nair A; Hsieh JT; Tang L
Adv Biosyst; 2019 Sep; 3(9):e1900019. PubMed ID: 32648652
[TBL] [Abstract][Full Text] [Related]
11. The origin of prostate metastases: emerging insights.
Santoni M; Piva F; Scarpelli M; Cheng L; Lopez-Beltran A; Massari F; Iacovelli R; Berardi R; Santini D; Montironi R
Cancer Metastasis Rev; 2015 Dec; 34(4):765-73. PubMed ID: 26363603
[TBL] [Abstract][Full Text] [Related]
12. Tumor-derived CXCL8 signaling augments stroma-derived CCL2-promoted proliferation and CXCL12-mediated invasion of PTEN-deficient prostate cancer cells.
Maxwell PJ; Neisen J; Messenger J; Waugh DJ
Oncotarget; 2014 Jul; 5(13):4895-908. PubMed ID: 24970800
[TBL] [Abstract][Full Text] [Related]
13. HIC1 loss promotes prostate cancer metastasis by triggering epithelial-mesenchymal transition.
Hao M; Li Y; Wang J; Qin J; Wang Y; Ding Y; Jiang M; Sun X; Zu L; Chang K; Lin G; Du J; Korinek V; Ye DW; Wang J
J Pathol; 2017 Aug; 242(4):409-420. PubMed ID: 28466555
[TBL] [Abstract][Full Text] [Related]
14. CXCR4 and CXCL12 (SDF-1) in prostate cancer: inhibitory effects of human single chain Fv antibodies.
Vaday GG; Hua SB; Peehl DM; Pauling MH; Lin YH; Zhu L; Lawrence DM; Foda HD; Zucker S
Clin Cancer Res; 2004 Aug; 10(16):5630-9. PubMed ID: 15328206
[TBL] [Abstract][Full Text] [Related]
15. Circulating tumor cells from prostate cancer patients interact with E-selectin under physiologic blood flow.
Gakhar G; Navarro VN; Jurish M; Lee GY; Tagawa ST; Akhtar NH; Seandel M; Geng Y; Liu H; Bander NH; Giannakakou P; Christos PJ; King MR; Nanus DM
PLoS One; 2013; 8(12):e85143. PubMed ID: 24386459
[TBL] [Abstract][Full Text] [Related]
16. The role of CXCR7/RDC1 as a chemokine receptor for CXCL12/SDF-1 in prostate cancer.
Wang J; Shiozawa Y; Wang J; Wang Y; Jung Y; Pienta KJ; Mehra R; Loberg R; Taichman RS
J Biol Chem; 2008 Feb; 283(7):4283-94. PubMed ID: 18057003
[TBL] [Abstract][Full Text] [Related]
17. Erythropoietin supports the survival of prostate cancer, but not growth and bone metastasis.
Shiozawa Y; McGee S; Pienta MJ; McGregor N; Jung Y; Yumoto K; Wang J; Berry JE; Pienta KJ; Taichman RS
J Cell Biochem; 2013 Nov; 114(11):2471-8. PubMed ID: 23696192
[TBL] [Abstract][Full Text] [Related]
18. Disseminated tumor cells and dormancy in prostate cancer metastasis.
van der Toom EE; Verdone JE; Pienta KJ
Curr Opin Biotechnol; 2016 Aug; 40():9-15. PubMed ID: 26900985
[TBL] [Abstract][Full Text] [Related]
19. Mesenchymal stem cells in prostate cancer have higher expressions of SDF-1, CXCR4 and VEGF.
Ding G; Wang L; Xu H; Xu Z; Feng C; Ding Q; Fang Z; Wu Z; Jiang H; Xu J; Gao P
Gen Physiol Biophys; 2013 Jun; 32(2):245-50. PubMed ID: 23682021
[TBL] [Abstract][Full Text] [Related]
20. The importance of the CXCL12-CXCR4 chemokine ligand-receptor interaction in prostate cancer metastasis.
Arya M; Patel HR; McGurk C; Tatoud R; Klocker H; Masters J; Williamson M
J Exp Ther Oncol; 2004 Dec; 4(4):291-303. PubMed ID: 15844659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
